期刊文献+

RKIP低表达与食管鳞状细胞癌浸润、转移及预后的相关性 被引量:1

下载PDF
导出
摘要 目的探讨RKIP表达与食管鳞状细胞癌浸润、转移及预后的关系。方法采用免疫组化法检测87例食管鳞状细胞癌及癌旁组织中RKIP的表达;采用甲基化特异性PCR(methylation-specific PCR,MSP)技术检测食管鳞状细胞癌及癌旁组织中RKIP的甲基化情况;采用Kaplan-Meier法评估食管鳞状细胞癌患者术后5年生存率;采用Cox比例风险模型分析RKIP对食管鳞状细胞癌患者预后的影响。结果食管鳞状细胞癌中RKIP的阳性率低于癌旁组织(P<0.05),RKIP表达与食管鳞状细胞癌的分化程度和淋巴结转移相关(P<0.05);食管鳞状细胞癌中RKIP基因启动子甲基化阳性率高于癌旁组织(P<0.05);RKIP低表达与RKIP基因启动子甲基化相关(P<0.05);RKIP蛋白阳性组患者5年生存率明显高于RKIP蛋白阴性组(P<0.01);RKIP表达是食管鳞状细胞癌的独立预后因素。结论食管鳞状细胞癌RKIP基因启动子甲基化是导致RKIP低表达的原因之一,RKIP低表达与食管鳞状细胞癌的浸润、转移及预后有关,有望成为食管鳞状细胞癌分子治疗的靶点。
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2015年第8期911-913,共3页 Chinese Journal of Clinical and Experimental Pathology
  • 相关文献

参考文献10

  • 1A1Mulla F, Bitar M S, Thiery J P, et al. Clinical implications for loss or diminution of expression of Rafl kinase inhibitopy protein and its phosphorylated fo:a in ductal breast cancer [ Jl. Am J Cancer Res, 2013,3 (5) :446 - 64.
  • 2李冬霞,张慧,汤正,武辉,李巧香.胃癌组织中RKIP基因启动子甲基化及蛋白表达[J].临床与实验病理学杂志,2014,30(4):376-378. 被引量:3
  • 3A1Mulla F, Hagan S, Behbehani A I, et al. Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer pa- tients[J]. J Clin Oncol, 2006,24(36):5672-9.
  • 4Das S K, Bhutia S K, Sokhi U K, et al. Raf kinase inhibitor RKIP inhibits MDA9/synteninmediated metastasis in melanoma [J:. CancerRes, 2012,72(23):6217-26.
  • 5Kroslak T, Koch T, Kahl E, et al. Human phosphatidylethano- lamine-binding protein facilitates heterotrimeric G protein-depend- ent signaling [ J 1. J Biol Chem, 2001,276 (43) : 39772 - 8.
  • 6AL-Mulla F, Hagan S, A1-Ali W, et al. Raf kinase inhibitor pro- tein : mechanism of loss of expression and association with genomic instablility [ J ]. J Clin Pathol, 2008,61 (4) :524 - 9.
  • 7Fujimori Y, Inokuchi M, Takagi Y, et al. Prognostic value of RKIP and p-ERK in gastric eancer[J]. J Exp Clin Cancer Res, 2012,31 (1) :30.
  • 8Kim H S, Park S J, Lee K Y, et al. Reduced Raf-1 kinase inhibi- tor protein expression predicts less favorable outcomes in patients with hepatic eolorectal metastasis[ J]. Oneol Rep, 2012,28 (1) : 161 -71.
  • 9Song S P, Zhang S B, Li Z H, et al. Reduced expression of Raf kinase inhibitor protein correlates with poor prognosis in pancreatic cancer[ J ]. Clin Transl Oncol, 2012,14 ( 11 ) :848 - 52.
  • 10徐海源,王馨,沈文香,王李强,沈刚,陈敏斌,周丽娜.RKIP在肺鳞癌组织中的表达及其意义[J].中国肺癌杂志,2011,14(3):194-198. 被引量:3

二级参考文献21

  • 1Odabaei G, Chatteriee D, Jazirehi AR, et al. Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis. Adv Cancer Res, 2004, 91: 169-200.
  • 2Beshir AB, Ren G, Magpusao AN, et aI. Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett, 2010, 299(2): 137-149.
  • 3Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin Ther Targets, 2008, 12(10): 1275-1287.
  • 4Fu Z, Smith PC, Zhang L, et al. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst, 2003, 95(12): 878-889.
  • 5Xu YF, Yi Y, Qju SJ, et at. PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection. J Hepatol, 2010, 53(5): 872-879.
  • 6Lin K, Baritaki S, Militello L, et al. The role of B-RAF mutations in melanomaand the induction of EMT via dysregulation of the NF-kappaB/Snail/RKIP/ PTEN circuit Genes Cancer, 2010, 1 (5): 409-420.
  • 7A1-Mulla F, Hagan S, A1-AIi W, et al. Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability. J Clin PathoI, 2008, 61 (4): 524-529.
  • 8Li HZ, Gao Y, Zhao XL, et al. Effects of rafkinase inhibitor protein expression on metastasis and progression of human breast cancer. Mol Cancer Res, 2009, 7(6): 832-840.
  • 9Giangreco A, Groot KR, Janes SM. Lung cancer and lung stem cells: strange bedfellows? AmJ Respir Crit Care Med, 2007, 175(6): 547-553.
  • 10Lee HC, Tian B, Sedivy JM, et al. Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology; 2006, 131(4): 1208-1217.

共引文献4

同被引文献1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部